Genmab CEO says lower operating costs are a fleeting phenomenon
![Photo: Tuala Hjarnø / Genmab / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13453391.ece/ALTERNATES/schema-16_9/doc7icrhic6ir61621zkn65.jpg)
Before Wedneday's quarterly report from Genmab was released, the biotech company had already upgraded its 2021 financial guidance for revenue and operating result.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.